Matthew D. Ringel

32.3k citations

176 papers · 9.1k indexed · 2 hit papers · h-index 55

Impact in

Endocrinology, Diabetes and Metabolism top 0.1%
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Disorders and Treatments
Cancer Research top 1%

Papers in

Endocrinology, Diabetes and Metabolism 111
- Thyroid Cancer Diagnosis and Treatment 103
- Thyroid Disorders and Treatments 16
Oncology 47
- Cancer-related Molecular Pathways 34

Co-authors: Motoyasu Saji Richard T. Kloos Kenneth D. Burman Gary L. Francis Fadi Nabhan Charis Eng Michael A. Levine Paul W. Ladenson
Journals: The Journal of Clinical Endocrinology & Metabolism (38 papers)Thyroid (24 papers)Endocrine Related Cancer (14 papers)Journal of Clinical Oncology (5 papers)Otolaryngology (5 papers)
Partner nations: United States Australia France

In The Last Decade

Matthew D. Ringel

171 papers receiving 8.9k citations

Hit Papers

align trajectories log scale

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer 2025 · 16 citations

Peers

Countries citing papers authored by Matthew D. Ringel

Since Specialization

Citations

This map shows the geographic impact of Matthew D. Ringel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Ringel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Ringel more than expected).

Fields of papers citing papers by Matthew D. Ringel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Ringel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Ringel. The network helps show where Matthew D. Ringel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Matthew D. Ringel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew D. Ringel Line = papers co-authored together Matthew D. Ringel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Germline POT1 Variants in a Pan-Cancer Cohort JCO Precision Oncology ·Pamela Brock, M. N. Webster, Sandya Liyanarachchi, Lindsey Byrne, Dale J. Hedges, Pat Gulhati, J. Kevin Hicks, Carlos H.F. Chan, Kenan Onel, Abby Motz, Hyeong Deok Yoon, Yen-Yi Lu, Juvianee Estrada‐Veras, Bodour Salhia, Lisen Axell, Laura L. Holman, Mohamed H. Abdel‐Rahman, Matthew D. Ringel	2025	0
2	mLumiOpto Is a Mitochondrial-Targeted Gene Therapy for Treating Cancer Cancer Research ·E. Tekin, P Ernst, Friederike Bock, Seulhee Kim, Yingnan Si, Qianran Chen, Matthew D. Ringel, Margaret Liu, Lufang Zhou	2024	7
3	CHEK2 Founder Variants and Thyroid Cancer Risk Thyroid ·Pamela Brock, P. Edgerton, Taina T. Nieminen, Carlos H.F. Chan, Wendy Kohlmann, Abby Motz, Song Yao, दीपा िैन, Norman Butler, Jill Kolesar, Bodour Salhia, Pat Gulhati, J. Kevin Hicks, Matthew D. Ringel	2024	4
4	Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo Clinical Cancer Research ·Martin L. Read, 秀昭島路, „Morstein ahn den König Casimirum aus Copenhagen vom 30 Septembris anno 1657”, Selvambigai Manivannan, Jana Kim, В.В. Кнышова, Alice Fletcher, Caroline M. Gorvin, Ailbhe Honohan, Gilbert O. Fruhwirth, Juan P. Nicola, Sissy Jhiang, Matthew D. Ringel, Moray J. Campbell, Kavitha Sunassee, Philip J. Blower, Kristien Boelaert, P. M. Adler, Vicki E. Smith, Christopher J. McCabe	2023	8
5	Inhibiting BRAF Oncogene–Mediated Radioresistance Effectively Radiosensitizes BRAFV600E-Mutant Thyroid Cancer Cells by Constraining DNA Double-Strand Break Repair Clinical Cancer Research ·Ryan Robb, Linlin Yang, Changxian Shen, Adam R. Wolfe, Amy Webb, Xiaoli Zhang, Marall Vedaie, Motoyasu Saji, Sissy Jhiang, Matthew D. Ringel, Terence M. Williams	2019	39
6	Compensation, Productivity, and Other Demographics of Academic Divisions of Endocrinology, Diabetes, and Metabolism Journal of the Endocrine Society ·Matthew D. Ringel, Elizabeth J. Murphy, Stephen R. Hammes	2019	3
7	Germline compound heterozygous poly-glutamine deletion inUSF3may be involved in predisposition to heritable and sporadic epithelial thyroid carcinoma Human Molecular Genetics ·Ying Ni, 李绪金, Benjamin Fletcher, Todd Romigh, Lamis Yehia, Jessica L. Mester, Leigha Senter, Farshad Niazi, Motoyasu Saji, Matthew D. Ringel, Thomas LaFramboise, Charis Eng	2016	13
8	Breast Cancer–Specific miR Signature Unique to Extracellular Vesicles Includes “microRNA-like” tRNA Fragments Molecular Cancer Research ·森克平, Kitty Agarwal, D. Asthagiri, Lianbo Yu, Motoyasu Saji, Matthew D. Ringel, Michael E. Paulaitis	2015	76
9	Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells Endocrine Related Cancer ·Yuyu Liu, Xiaoli Zhang, Matthew D. Ringel, Sissy Jhiang	2012	35
10	Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53 Human Molecular Genetics ·Ying Ni, Xin He, Jinlian Chen, Jessica Moline, Jessica L. Mester, Mohammed S. Orloff, Matthew D. Ringel, Charis Eng	2011	76
11	Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro Endocrine Related Cancer ·Yoon Woo Koh, Manisha H. Shah, Kitty Agarwal, Abderrahman Aqlibous, Bon Seok Koo, ARTHUR RIFKIN, Chaojie Wang, Kyle Porter, David Jarjoura, Motoyasu Saji, Matthew D. Ringel	2011	32
12	Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma Carcinogenesis ·Khelifa Arab, Laura T. Smith, Andreas Gast, Dieter Weichenhan, Po-Hsien Huang, Rainer Claus, Thomas Hielscher, Allan V. Espinosa, Matthew D. Ringel, Quaid Morris, Dirk Schadendorf, Rajiv Kumar, Christoph Plass	2011	56
13	Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer Proceedings of the National Academy of Sciences ·Krystian Jażdżewski, Sandya Liyanarachchi, Michał Świerniak, Janusz Pachucki, Matthew D. Ringel, Barbara Jarząb, Albert de la Chapelle	2009	260
14	Regulation of actin function by protein kinase A‐mediated phosphorylation of Limk1 EMBO Reports ·Leonardo Ferres, Motoyasu Saji, Naduparambil K. Jacob, Maryluce Albuquerque Silva Campos, Matthew D. Ringel, Lawrence S. Kirschner	2009	66
15	Phase II Trial of Sorafenib in Metastatic Thyroid Cancer Journal of Clinical Oncology ·Richard T. Kloos, Matthew D. Ringel, Michael V. Knopp, Nathan C. Hall, Mark A. King, Robert C. Stevens, Jiachao Liang, Paul E. Wakely, Vasyl Vasko, Motoyasu Saji, Andrew Gent, Lai Wei, Daria Arbogast, Minden Collamore, James R. Wright, Michael R. Grever, Manisha H. Shah	2009	430
16	Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion Proceedings of the National Academy of Sciences ·Vasily Vasko, Allan V. Espinosa, Sofia Gakhar, Huiling He, Herbert Auer, Sandya Liyanarachchi, О. С. Ларін, В. Н. Савченко, Gary L. Francis, Albert de la Chapelle, Motoyasu Saji, Matthew D. Ringel	2007	270
17	Beyond peroxisome proliferator-activated receptor γ signaling: the multi-facets of the antitumor effect of thiazolidinediones Endocrine Related Cancer ·P. SANTEMA, Ching‐Yu Chen, Joseph J. Pinzone, Matthew D. Ringel, Chen‐Li Cheng	2006	113
18	OSU03012, a novel PDK1 inhibitor, decreases thyroid cancer proliferation and migration via multiple downstream pathways. Cancer Research ·Leonardo M. Porchia, Marcy L. Guerra, Allan V. Espinosa, Motoyasu Saji, Samuel K. Kulp, Matthew D. Ringel, Ching‐Shih Chen	2006	1
19	Genetic Classification of Benign and Malignant Thyroid Follicular Neoplasia Based on a Three-Gene Combination The Journal of Clinical Endocrinology & Metabolism ·Frank Weber, Lei Shen, Micheala A. Aldred, Carl Morrison, Andrea Frilling, Motoyasu Saji, Frank Schuppert, Christoph E. Broelsch, Matthew D. Ringel, Charis Eng	2005	122
20	Metastin Receptor Is Overexpressed in Papillary Thyroid Cancer and Activates MAP Kinase in Thyroid Cancer Cells The Journal of Clinical Endocrinology & Metabolism ·Matthew D. Ringel	2002	34

About Matthew D. Ringel

Matthew D. Ringel is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 176 papers that have together received 9.1k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (103 papers), Cancer-related Molecular Pathways (34 papers), PI3K/AKT/mTOR signaling in cancer (22 papers), Thyroid Disorders and Treatments (16 papers), BRCA gene mutations in cancer (15 papers), Thyroid and Parathyroid Surgery (13 papers), Head and Neck Anomalies (12 papers) and Genetic factors in colorectal cancer (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.1k citations), Cancer Research (1.2k citations), Oncology (2.1k citations), Molecular Biology (3.6k citations) and Genetics (1.3k citations). Matthew D. Ringel has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Motoyasu Saji, Richard T. Kloos, Kenneth D. Burman, Gary L. Francis, Fadi Nabhan, Charis Eng, Michael A. Levine, Paul W. Ladenson, Vasily Vasko and Jeffrey F. Moley. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Thyroid, Endocrine Related Cancer, Journal of Clinical Oncology and Otolaryngology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact